Baltimore’s SilcsBio LLC has earned a U.S. patent covering key elements of its drug design software, which it hopes will help validate its technology as unique in the pharmaceutical market. The company’s software is sold to and used by pharmaceutical companies to assist in the processes of developing new and patentable drugs. The newly-issued patent covers the algorithms used for a process called site-identification by ligand competitive saturation (SILCS). As Tina Guvench, SilcsBio’s technical…
from https://www.bizjournals.com/baltimore/news/2018/07/18/baltimore-firm-secures-patent-for-pharma-software.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/176019870337
No comments:
Post a Comment